Jun 08, 2023

Interviewing for a royalty fund - advice?

I'm interviewing for a royalty fund and am from a biotech background. What kind of modeling exercises should I expect? While I'm pretty familiar with PE modeling, I'm not too familiar with royalties and have heard they operate similar to private credit. Any tips on stuff to study?

Also is this a good space to go into right now given macro environment? What will exit opps be like? Royalties seem like a tough market especially for drugs, but I might be wrong.

2 Comments
 
Most Helpful

Royalties are easy. Its a basic cash flow stream PV primarily sensitized against price x volume and tenor. If the PV is 100 you can think about advancing credit on an LTV basis, i.e., 40% LTV is 40 on the 100. Your P&I comes off the top so royalties are structurally senior to more traditional debt in a cash flow waterfall and should also have a priority lien on the royalty itself. There is a lot of room for creativity with structuring these credits. Some are for the life of the royalty, some have a defined maturity like a regular bond, and some terminate once a pre-determined IRR/MOIC target is hit. There is also a pretty good market for royalties, so monetizing your collateral is relatively straight forward in a default, or alternatively you just hold onto it and harvest the cash flows. The overhead requirement for managing royalties is practically zero and very scalable. There are some publicly traded aggregators of life science / pharma royalties out there and their investor presentations would probably be helpful for you. Royalty Pharma (RPRX) is an example. 

 

Quis minus natus deserunt omnis quam aut rem. Sit debitis quos esse alias.

Omnis fugiat laborum esse eius sequi. Omnis a atque aut asperiores. Exercitationem rerum voluptatem atque.

Error eligendi in architecto. Quo modi aut porro sunt est. Aut libero qui et.

Enim nulla expedita earum animi minus. Iste consequatur dignissimos blanditiis doloremque eum consectetur.

Career Advancement Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 08 98.4%
  • JPMorgan No 97.9%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

September 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.3%

Total Avg Compensation

September 2026 Investment Banking

  • Vice President (16) $429
  • Associates (53) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (15) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”